Vallier, Cédric <br/><br/>
External validation of the Heidenreich criteria for patient selection for unilateral or bilateral retroperitoneal lymph node dissection for post-chemotherapy residual masses of testicular cancer.  [electronic resource] 

 -  World journal of urology  Dec 2014 
 - 1573-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1433-8726 
<br/><br/><label>Standard No.: </label>10.1007/s00345-014-1240-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Agents--therapeutic use<br/>Cohort Studies<br/>Combined Modality Therapy<br/>Disease-Free Survival<br/>Humans<br/>Lymph Node Excision<br/>Male<br/>Neoplasm Recurrence, Local--diagnosis<br/>Neoplasm, Residual<br/>Neoplasms, Germ Cell and Embryonal--diagnosis<br/>Patient Selection<br/>Reproducibility of Results<br/>Retroperitoneal Space<br/>Testicular Neoplasms--diagnosis